Parkinson's Disease Trial, Recruiting NCT07644013 Sponsor: Peking University First Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07644013
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with multiple system atrophy (a condition affecting movement and body functions) based on recognised 2022 diagnostic guidelines.
  • You have been diagnosed with Parkinson's disease based on recognised diagnostic guidelines.
  • You are a healthy person, or someone without an inherited or brain-degenerating condition, who is willing to take part as a comparison participant.
  • You are between 40 and 75 years of age.
  • You are able to give your own consent to participate, or someone legally authorised to act on your behalf can do so.

Who may not be able to join:

  • You have Parkinson's-like symptoms that doctors have not been able to clearly identify as either Parkinson's disease or multiple system atrophy.
  • You have been diagnosed with, or are suspected of having, another related brain condition such as progressive supranuclear palsy, dementia with Lewy bodies, or corticobasal syndrome.
  • Your Parkinson's-like symptoms are caused by something else, such as a brain tumour, fluid build-up in the brain, medication side effects, or another known cause.
  • You have another health condition that significantly affects how your body's automatic functions work (like automatic control of heart rate or digestion), such as nerve damage from diabetes or a condition called amyloidosis.
  • You are unwilling to take part or unwilling to undergo standard clinical assessments for Parkinson's-like conditions.
  • You have psychiatric or behavioural difficulties that would make it hard to reliably collect information or complete assessment questionnaires (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in disease severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov